APhA Statement Related to Texas District Court Decision Regarding Mifepristone
April 08, 2023
April 08, 2023
WASHINGTON, April 8 (TNStalk) -- The American Pharmacists Association issued the following statement on April 7, 2023:
* * *
The American Pharmacists Association released the following statement in response to the decision in the Alliance for Hippocratic Medicine v U.S. Food and Drug Administration lawsuit file in the US District Court for the Northern District of Texas, regarding FDA approval of mifepristone.
"APhA and our nation's pharmacists stand . . .
* * *
The American Pharmacists Association released the following statement in response to the decision in the Alliance for Hippocratic Medicine v U.S. Food and Drug Administration lawsuit file in the US District Court for the Northern District of Texas, regarding FDA approval of mifepristone.
"APhA and our nation's pharmacists stand . . .